Sex Differences in Long-Term Outcomes in Patients With Chronic Coronary Syndrome After Percutaneous Coronary Intervention　― Insights From a Japanese Real-World Database Using a Storage System

• Published in: Circulation Journal 2023/05/25, Vol.87(6), pp.775-782
• Main Authors: Akashi, Naoyuki, Matoba, Tetsuya, Kohro, Takahide, Oba, Yusuke, Kabutoya, Tomoyuki, Imai, Yasushi, Kario, Kazuomi, Kiyosue, Arihiro, Mizuno, Yoshiko, Nochioka, Kotaro, Nakayama, Masaharu, Iwai, Takamasa, Miyamoto, Yoshihiro, Ishii, Masanobu, Nakamura, Taishi, Tsujita, Kenichi, Sato, Hisahiko, Fujita, Hideo, Nagai, Ryozo, on behalf of the CLIDAS Research Group
• Format: Article
• Language: English
• Subjects: Chronic coronary syndrome; Clinical Deep Data Accumulation System (CLIDAS); Cohort Studies; Coronary Disease - epidemiology; East Asian People; Female; Humans; Male; Percutaneous coronary intervention; Percutaneous Coronary Intervention - adverse effects; Percutaneous Coronary Intervention - methods; Real-world database; Retrospective Studies; Sex differences; Sex Factors
• ISSN: 1346-9843; 1347-4820; 1347-4820
• DOI: 10.1253/circj.CJ-22-0653

Background: Several studies have reported some sex differences in patients with coronary artery diseases. However, the results regarding long-term outcomes in patients with chronic coronary syndrome (CCS) are inconsistent. Therefore, the present study investigated sex differences in long-term outcomes in patients with CCS after percutaneous coronary intervention (PCI).Methods and Results: This was a retrospective, multicenter cohort study. We enrolled patients with CCS who underwent PCI between April 2013 and March 2019 using the Clinical Deep Data Accumulation System (CLIDAS) database. The primary outcome was major adverse cardiovascular events (MACE), defined as a composite of cardiovascular death, non-fatal myocardial infarction, or hospitalization for heart failure. In all, 5,555 patients with CCS after PCI were included in the analysis (4,354 (78.4%) men, 1,201 (21.6%) women). The median follow-up duration was 917 days (interquartile range 312–1,508 days). The incidence of MACE was not significantly different between the 2 groups (hazard ratio [HR] 1.20; 95% confidential interval [CI] 0.97–1.47; log-rank P=0.087). After performing multivariable Cox regression analyses on 4 different models, there were still no differences in the incidence of MACE between women and men.Conclusions: There were no significant sex differences in MACE in patients with CCS who underwent PCI and underwent multidisciplinary treatments.